|
| Commodity | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 |
| Penicillins & their derivs. with a penicillanic acid structure; salts there ... | $41,505,077 | $35,700,627 | $30,310,684 | $25,529,568 | $45,458,401 | $37,438,326 | $43,016,780 |
| Streptomycins & their derivs.; salts thereof | $889,435 | $817,278 | $961,709 | $1,295,984 | $650,971 | $81,302 | $71,144 |
| Tetracyclines & their derivs.; salts thereof | $90,910,320 | $21,573,215 | $29,449,775 | $62,000,870 | $27,922,022 | $21,486,488 | $35,314,982 |
| Chloramphenicol & its derivs.; salts thereof | $53,205 | $86,589 | $115,001 | $188,371 | $75,104 | $55,579 | $43,200 |
| Erythromycin & its derivs.; salts thereof | $1,956,473 | $44,896 | $94,555,259 | $36,466,864 | $50,345,109 | $41,009,685 | $42,677,770 |
| Antibiotics & their derivs. (excl. of 2941.10-2941.50); salts thereof | $819,640,853 | $504,566,699 | $582,366,518 | $616,799,876 | $725,750,614 | $523,341,115 | $588,670,049 |
| Total | $954,955,363 | $562,789,304 | $737,758,946 | $742,281,533 | $850,202,221 | $623,412,495 | $709,793,925 |
|
|
